Beranda › Penyakit Graft-versus-Host
Uji klinis Penyakit Graft-versus-Host yang merekrut di AS
34 studi untuk Penyakit Graft-versus-Host merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Boston, MA10 studi
- New York City, NY7 studi
- Columbus, OH6 studi
- Atlanta, GA5 studi
- Washington, DC5 studi
- Pittsburgh, PA4 studi
- Detroit, MI4 studi
- Tampa, FL4 studi
- Baldwin Park, CA4 studi
- Portland, OR4 studi
- St. Louis, MO4 studi
- Miami, FL4 studi
- Queens, NY4 studi
- Seattle, WA4 studi
- Nashville, TN3 studi
- Cleveland, OH3 studi
- Chicago, IL3 studi
- Los Angeles, CA3 studi
- Edison, NJ3 studi
- New Rochelle, NY3 studi
- East Norwalk, CT3 studi
- Greenburgh, NY3 studi
- Staten Island, NY3 studi
- Houston, TX3 studi
Berdasarkan negara bagian
- California9 studi
- Florida7 studi
- Georgia5 studi
- Illinois3 studi
- Kansas3 studi
- Maryland5 studi
- Massachusetts10 studi
- Michigan5 studi
- Missouri4 studi
- New Jersey4 studi
- New York10 studi
- Ohio7 studi
- Oregon4 studi
- Pennsylvania6 studi
- Tennessee3 studi
- Texas4 studi
- Washington4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00001529Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
Menerima pesertaStudi observasional
Usia 18 hingga 70 · Wanita · Diperbarui 29 Sep 2026 · NCT06649201Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Menerima pesertaFase 1/2
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05531786Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06910969Evaluation of Patients With Immune Function Abnormalities
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00128973Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 7 hingga 80 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT00106925Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT06450925Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Menerima pesertaFase 1
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06392711Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07565220Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
Menerima pesertaFase 1
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06991361A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07359859Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07216443Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT06996119A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07006506Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06815003A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Menerima pesertaFase 2
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT04710576Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
Menerima pesertaFase 1/2
Usia 14 hingga 100 · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05289167A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
Menerima pesertaFase 2
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT05675930A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06615050Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Menerima pesertaFase 2
Hingga usia 26 · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT07566377Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
Menerima pesertaFase 2
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT04380740Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT06008808Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT07356245Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT06434363A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
Menerima peserta
Hingga usia 30 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT04337515Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.